CIK: 0002013341
Total reported value
$460.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CGON | Cg Oncology INC | Stock-Other | 28.39% | +4.79% | — | |
| 2 | ALMS | Alumis INC | Stock-Other | 14.72% | +7.80% | — | |
| 3 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 9.35% | +1.46% | — | |
| 4 | ✓ | Rapt Therapeutics INC | Stock-Other | 8.80% | — | — | |
| 5 | BCAX | Bicara Therapeutics INC | Stock-Other | 7.37% | — | — | |
| 6 | EWTX | Edgewise Therapeutics INC | Stock-Other | 6.96% | — | — | |
| 7 | GPCR | Structure Therapeutics INC | Stock-Other | 5.08% | — | — | |
| 8 | AKRO | Akero Therapeutics INC | Stock-Other | 4.52% | — | — | |
| 9 | CRVS | Corvus Pharmaceuticals INC | Stock-Other | 3.77% | +2.61% | — | |
| 10 | CGEM | Cullinan Therapeutics INC | Stock-Other | 3.44% | — | — | |
| 11 | ALLO | Allogene Therapeutics INC | Stock-Other | 3.27% | — | — | |
| 12 | KYMR | Kymera Therapeutics INC | Stock-Other | 2.62% | -0.79% | — | |
| 13 | ✓ | Casi Pharmaceuticals INC | Stock-Other | 1.68% | — | — | |
| 14 | VRDN | Viridian Therapeutics INC | Stock-Other | 0.02% | — | — |